Hibiki Path Advisors Finalized Its Policy to Oppose ‘  the Proposed Transition to a Company With an Audit and Supervisory Committee and ‘¡ the Election of Certain Director Candidates for the 54th An

Hibiki Path Advisors, the largest shareholder of JAPAN PURE CHEMICAL CO., LTD. (TSE: 4973), announced its voting policy for the upcoming AGM, opposing the proposed transition to a company with an Audit and Supervisory Committee due to concerns over board independence and effectiveness. While supporting the reappointment of President Tomoyuki Kojima and Outside Director Momoe Kuromatsu, Hibiki Path Advisors opposes the appointment of all other directors, particularly Director Masao Watanabe, citing a lack of progress in improving asset efficiency and corporate value under his leadership; Hibiki Path Advisors has conditioned their support for Mr. Kojima on fundamental capital allocation reforms within his one-year term.

Analysis

Hibiki Path Advisors, as the largest shareholder of JAPAN PURE CHEMICAL CO., LTD. (JPC, TSE: 4973), has formally declared its opposition to the company's proposed transition to an Audit and Supervisory Committee (ASC) structure, citing serious concerns that the move is 'purely ceremonial' and risks further entrenching the current internal executive team despite their 'ongoing failure to implement fundamental reforms.' Hibiki argues that the proposed board expansion to ten members, constituting nearly 20% of JPC's workforce, could slow decision-making and dilute governance, particularly as outside directors are perceived to be predominantly from a 'specific corporate group,' thus lacking true independence. Regarding director elections for the June 20, 2025 AGM, Hibiki supports only the reappointment of President Tomoyuki Kojima and Outside Director Momoe Kuromatsu, the latter being viewed as the sole independent candidate. Support for Mr. Kojima is notably conditional upon 'fundamental capital allocation reforms within his one-year term.' Hibiki strongly opposes the reappointment of Director and Honorary Advisor Masao Watanabe, attributing JPC's 'continuous decline in operating profit and ROE' and capital misallocation to his approximately 25-year management involvement. This stance, particularly on Mr. Kojima, diverges from ISS recommendations, with Hibiki asserting that Mr. Watanabe bears primary responsibility for past failures. The activist shareholder also highlighted JPC's lack of transparency, noting that requests for board meeting minutes and individual meetings with director candidates were largely denied. The strongly negative sentiment (-0.8 for JPC) and high market impact score (0.7) underscore the significance of this governance battle, which could lead to substantial board changes if Hibiki's positions prevail, potentially leaving JPC below the statutory minimum number of directors and necessitating an Extraordinary General Meeting.

Key Decisions for Investors

• Investors should recognize the significant activist pressure from JAPAN PURE CHEMICAL CO., LTD.'s largest shareholder, portending potential management and strategic shifts contingent on the AGM outcomes.
• Monitor the June 20, 2025, AGM results closely, as votes on the Audit and Supervisory Committee transition and director elections will be critical indicators of shareholder alignment and the future board composition.
• Consider the heightened uncertainty surrounding President Kojima's tenure, which is explicitly conditioned on delivering substantial capital allocation reforms within one year, impacting JPC's strategic execution and financial outlook.
• Be prepared for increased stock volatility in JPC (TSE: 4973) due to the ongoing governance dispute, the strongly negative sentiment, and the potential for significant board restructuring.